
Latest Insights on NTLA

February 6, 2022 Great Stuff
Comfy Like An Old Pair Of Genes Good morning, all ye Great Ones! Sunday brunch time is upon us once again, and this time, I hope you brought your appetites for weird science. Ugh, why is it always about food with you people? Quiet, you. ‘Twas just a few weeks ago that we gorged ourselves […]
December 7, 2021 Trading Strategies, Winning Investor Daily
When the market moves this much, day trading has the potential to be lucrative. 
July 6, 2021 Investment Opportunities, Technology, Winning Investor Daily
Gene editing aims to cure diseases by replacing faulty genes with the healthy variant. That means no more monthly trips to the doctor.
June 28, 2021 Great Stuff
Wall Street’s Weird Science ♫ From my heart and from my hand, why don’t people understand … my intentions? ♫ Great Ones, did you see what happened in the biotech market today? Holy cow … it was poetry in motion. Intellia Therapeutics (Nasdaq: ) skyrocketed more than 50% after early trial data showed the company’s […]
August 15, 2019 American Investor Today, Investment Opportunities, Technology
Name brands are struggling to keep consumers’ loyalty. People opt for store or private-label brands that offer the same, if not better, quality than name brands at a better price. But there’s one sector where name brands still drive sales and revenue. Charles Mizrahi sees huge gains coming from name brands in this industry. (6-minute read)